Showing results (301-310 of 653) with videos related to

Sort By:
Pageof 66
Annals of Surgical Oncology|May 26, 2005
Paget's disease of the breast: there is a role for breast-conserving therapyKazumi Kawase, Dominick J Dimaio, Susan L Tucker, et al.
Oncotarget|July 9, 2014
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester diseaseFilip Janku, Cecile Rose T Vibat, Karena Kosco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, NeratinibGary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
American Journal of Surgery|September 11, 2007
Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomyThao Vo, Yan Xing, Funda Meric-Bernstam, et al.
Oncotarget|September 22, 2018
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinicVikas Dembla, Neeta Somaiah, Pedro Barata, et al.
Signal Transduction and Targeted Therapy|February 23, 2026
Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncologyStephanie T Schmidt, Mehmet A Baysal, Siqing Fu, et al.
Cancer|July 25, 2006
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapyFlorentia Peintinger, W Fraser Symmans, Ana M Gonzalez-Angulo, et al.
Nature|August 1, 2014
Clonal evolution in breast cancer revealed by single nucleus genome sequencingYong Wang, Jill Waters, Marco L Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trialAna M Gonzalez-Angulo, Funda Meric-Bernstam, Sant Chawla, et al.
Pageof 66